Nicotine Lozenges Market Consumption and Revenue Analysis by Top Key Vendors (GSK, Nicorette, Nicorette Mini Lozenge, Commit, Walgreens, Novartis, Basic Care) | Forecast to 2025

Overview of Global Nicotine Lozenges Market:

This report provides in-depth study of “Global Nicotine Lozenges Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Nicotine Lozenges Market report also provides an in-depth survey of key players in the market organization.

According to the market research study, Nicorette is the brand name of a number of products for Nicotine Replacement Therapy (NRT) that contains nicotine. Developed in the late 1970s in Sweden by AB Leo in the form of a chewing gum, Nicorette was the first nicotine replacement product on the market. In addition, Nicotine replacement products including gum and transdermal patches are on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/244346 .

Firstly, the report provides a basic overview of the Market including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major Market players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2020-2025 market shares for each company.

Through the statistical analysis, the report depicts the international Nicotine Lozenges Market including capacity, production, production value, cost/profit, supply/demand and global import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2020-2025 market development trends of Nicotine Lozenges industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of Nicotine Lozenges Market before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2025 global Nicotine Lozenges market covering all important parameters.

Global Key Vendors:

1 GlaxoSmithKline

2 Nicorette

3 Nicorette Mini Lozenge

4 Commit

5 Walgreens

6 Novartis

7 Basic Care and More……………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Nicotine Lozenges Market Report 2020” @ https://www.businessindustryreports.com/buy-now/244346/single .

Product Type Segmentation

1 Gluten Free

2 Latex-Free

3 No Animal Derived Ingredients

Industry Segmentation

1 Male

2 Female

Global Medical Industry News:

GlaxoSmithKline (GSK) (May 18, 2020) - Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP - ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the interim analysis of the HIV Prevention Trials Network (HPTN) 083 study evaluating the safety and efficacy of investigational, long-acting, injectable cabotegravir for HIV prevention. In the study cabotegravir was found to be 69% more effective (95% CI 41%-84%) in preventing HIV acquisition in men who have sex with men (MSM) and transgender women who have sex with men when compared to the current standard of care, daily oral emtricitabine/tenofovir disoproxil fumarate 200 mg and 300 mg (FTC/TDF) tablets. The study achieved its primary objective of non-inferiority with the difference approaching superiority in favour of cabotegravir, pending final analysis.

The HPTN 083 study, with approximately 4,600 participants across more than 40 sites in North and South America, Asia, and Africa, is one of the first-ever clinical trials to directly compare two active prevention agents. In a planned interim review, the independent Data and Safety Monitoring Board (DSMB) found the study data clearly indicated that long-acting injectable cabotegravir was highly effective at preventing HIV in the study population. Among the 50 people in the trial who acquired HIV, 12 were randomised to the long-acting cabotegravir arm and 38 were randomised to the daily, oral FTC/TDF arm. This translated to an HIV incidence rate of 0.38% (95% confidence interval [CI] 0.20%-0.66%) in the cabotegravir group and 1.21% (95% CI 0.86%-1.66%) in the FTC/TDF group. Adherence to oral FTC/TDF was high, based on a random subset sampling that detected tenofovir (> 0.31 ng/ml) in 87% of all samples tested. Despite this high level of adherence to oral therapy, long-acting cabotegravir was 69% (95% CI 41%-84%) more effective than FTC/TDF in preventing HIV acquisition in the study population.

Myron S. Cohen, M.D., Co-Principal Investigator of the HPTN and the Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina (UNC) at Chapel Hill, said: “Each year, an estimated 1.7 million people are newly diagnosed with HIV. To lower that number, we believe more prevention options are needed in addition to currently available oral tablets for daily use. If approved, a new injectable agent, such as long-acting cabotegravir administered every two months, could play an important role in reducing HIV transmission and helping to end the HIV epidemic.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/244346 .

Major Points in Table of Contents:

Global Nicotine Lozenges Market Report 2020

1 Nicotine Lozenges Product Definition

2 Global Nicotine Lozenges Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Nicotine Lozenges Shipments

2.2 Global Manufacturer Nicotine Lozenges Business Revenue

2.3 Global Nicotine Lozenges Market Overview

3 Manufacturer Nicotine Lozenges Business Introduction

3.1 Glaxo Nicotine Lozenges Business Introduction

3.2 Nicorette Nicotine Lozenges Business Introduction

3.3 Nicorette Mini Lozenge Nicotine Lozenges Business Introduction

3.4 Commit Nicotine Lozenges Business Introduction

3.5 Walgreens Nicotine Lozenges Business Introduction

3.6 Novartis Nicotine Lozenges Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.